Showing results (111-120 of 245) with videos related to

Sort By:
Pageof 25
Frontiers in Oncology|April 24, 2023
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in ItalyAndrea Casadei-Gardini, Francesco Leone, Giovanni Brandi, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
Oncotarget|April 20, 2017
Immunotherapeutic approaches for hepatocellular carcinomaVito Longo, Antonio Gnoni, Andrea Casadei Gardini, et al.
Future Oncology (London, England)|March 10, 2018
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiformeLorena Gurrieri, Elisa De Carlo, Lorenzo Gerratana, et al.
Frontiers in Immunology|February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysisLaura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 15, 2014
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover studyLuisa Foltran, Giuseppe Aprile, Federica Edith Pisa, et al.
Oncotarget|August 11, 2015
MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Oronzo Brunetti, Antonio Russo, Aldo Scarpa, et al.
Expert Review of Clinical Pharmacology|March 29, 2017
Immunotherapy for gastric cancers: emerging role and future perspectivesMarta Bonotto, Silvio Ken Garattini, Debora Basile, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2010
Treatment trends in metastatic pancreatic cancer patients: Is it time to change?Michele Reni, Lara Maria Pasetto, Alessandro Passardi, et al.
Anti-Cancer Drugs|January 30, 2010
An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?Michele Reni, Nora Sartori, Andrea Mambrini, et al.
Pageof 25